Andrew Reardon - 03 Aug 2026 Form 4 Insider Report for LIGAND PHARMACEUTICALS INC (LGND)

Reporting relationship: CLO & Secretary
Issuer ticker: LGND
Reported as of: 03 Aug 2026
Net transaction value: -$1,444,951
SEC form: 4
Accepted by SEC: 04 Aug 2026, 18:42:58 UTC
Prior SEC filing: 06 Jul 2026
Source filing: View source filing
Reporting owner signature: /s/Andrew Reardon

Key filing fact

Andrew Reardon filed Form 4 for LIGAND PHARMACEUTICALS INC (LGND) on 04 Aug 2026.

Key facts

This page summarizes Andrew Reardon's Form 4 filing for LIGAND PHARMACEUTICALS INC (LGND).
12 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 04 Aug 2026, 18:42.

Change

Previous filing in this sequence was filed on 06 Jul 2026.
Current net transaction value: -$1,444,951.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001950232 Primary reporting owner

Reardon Andrew

Relationship: CLO & Secretary
Address: 555 HERITAGE DRIVE, SUITE 200, JUPITER
Signature: /s/Andrew Reardon
Signature date: 04 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

LGND transaction

Common Stock

Options Exercise

Transaction value
Shares: +5,000
Change %: +12%
Price: $52.27^*
Shares after: 46,514
Date: 03 Aug 2026
Ownership: Direct
Footnotes: F1

LGND transaction

Common Stock

Sale

Transaction value: $29,834
Shares: -105
Change %: -0.23%
Price: $284.14
Shares after: 46,409
Date: 03 Aug 2026
Ownership: Direct
Footnotes: F1, F2

LGND transaction

Common Stock

Sale

Transaction value: $9,390
Shares: -33
Change %: -0.07%
Price: $284.55
Shares after: 46,376
Date: 03 Aug 2026
Ownership: Direct
Footnotes: F1, F3

LGND transaction

Common Stock

Sale

Transaction value: $44,861
Shares: -157
Change %: -0.34%
Price: $285.74
Shares after: 46,219
Date: 03 Aug 2026
Ownership: Direct
Footnotes: F1, F4

LGND transaction

Common Stock

Sale

Transaction value: $295,974
Shares: -1,032
Change %: -2.2%
Price: $286.80
Shares after: 45,187
Date: 03 Aug 2026
Ownership: Direct
Footnotes: F1, F5

LGND transaction

Common Stock

Sale

Transaction value: $349,357
Shares: -1,214
Change %: -2.7%
Price: $287.77
Shares after: 43,973
Date: 03 Aug 2026
Ownership: Direct
Footnotes: F1, F6

LGND transaction

Common Stock

Sale

Transaction value: $102,795
Shares: -356
Change %: -0.81%
Price: $288.75
Shares after: 43,617
Date: 03 Aug 2026
Ownership: Direct
Footnotes: F1, F7

LGND transaction

Common Stock

Sale

Transaction value: $145,771
Shares: -503
Change %: -1.2%
Price: $289.80
Shares after: 43,114
Date: 03 Aug 2026
Ownership: Direct
Footnotes: F1, F8

LGND transaction

Common Stock

Sale

Transaction value: $58,120
Shares: -200
Change %: -0.46%
Price: $290.60
Shares after: 42,914
Date: 03 Aug 2026
Ownership: Direct
Footnotes: F1, F9

LGND transaction

Common Stock

Sale

Transaction value: $289,086
Shares: -991
Change %: -2.3%
Price: $291.71
Shares after: 41,923
Date: 03 Aug 2026
Ownership: Direct
Footnotes: F1, F10

LGND transaction

Common Stock

Sale

Transaction value: $119,763
Shares: -409
Change %: -0.98%
Price: $292.82
Shares after: 41,514
Date: 03 Aug 2026
Ownership: Direct
Footnotes: F1, F11

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

LGND transaction Derivative

Employee Stock Option (right to buy)

Options Exercise

Transaction value
Shares: -5,000
Change %: -15%
Price: $0.000000^*
Shares after: 29,444
Date: 03 Aug 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 5,000
Exercise price: $52.27
Footnotes: F1, F12

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 12 footnotes

Footnote F1

The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on November 24, 2025, in accordance with Rule 10b5-1.

Footnote F2

The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $283.24 to $284.23. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F3

The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $284.28 to $284.58. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F4

The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $285.28 to $285.90. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F5

The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $286.28 to $287.17. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F6

The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $287.30 to $288.27. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F7

The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $288.32 to $289.20. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F8

The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $289.33 to $290.18. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F9

The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $290.48 to $290.72. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F10

The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $291.57 to $292.47. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F11

The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $292.78 to $292.89. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F12

The stock option vests and is exercisable as to 12.5% of the underlying shares on February 1, 2023, and in 42 substantially equal monthly installments thereafter.